Japan’s Takeda Pharma says full-year profit slid 9.5%
15:24 JST, May 11, 2022
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday that 12-month operating profit slid 9.5% from the previous year.
Operating profit for Japan’s largest drugmaker in the year that ended on March 31 came in at 461 billion yen ($3.54 billion).
That compares with its own earlier estimate of 515 billion yen and a consensus forecast of 509 billion yen from a Refinitiv poll of 15 analysts.
The company estimated the current fiscal year’s operating profit will rise to 520 billion yen.
($1 = 130.3700 yen)
"News Services" POPULAR ARTICLE
-
Tariffs to Cause ‘Short-term Bumps,’ Trump Economic Adviser Tells Fox Business
-
Trump’s Auto Tariffs to Cover Hundreds of Billions of Dollars Worth of Vehicle, Parts Imports
-
Fed’s Kugler Says Tariffs Could Touch off More Prolonged Inflation
-
Myanmar’s Earthquake Death Toll Jumps to More Than 1,000 as More Bodies Recovered From the Rubble (UPDATE 2)
-
Powerful Quake Rocks Myanmar and Thailand and Kills More than 150 People (Update3)
JN ACCESS RANKING